|
Product class:
|
Medicinal product with marketing authorization
|
|
Medicinal product class:
|
Veterinary medicine
|
|
Name of medicinal product:
|
Animedazon
|
|
Active substances:
|
|
|
ATC code:
|
QD06AA02
|
|
Dosage form:
|
cutaneous spray, suspension
|
|
Strength:
|
2,45% w/w
|
|
Legal status for supply*:
|
Subject to medicinal prescription
|
|
Summary of product characteristics (SPC):
|
 (last updated June 30, 2020)
|
|
Package information leaflet (PIL):
|
EST (last updated June 30, 2020)
|
|
Labelling:
|
(last updated July 29, 2016)
|
|
Indication:
|
Treatment of superficial traumatic or surgical wounds contaminated with chlortetracycline-sensitive agents. The product can be used as part of a treatment for superficial skin and claw infections, in particular interdigital dermatitis (foot rot and foul in the foot) and digital dermatitis caused by micro-organisms sensitive to chlortetracycline.
|
|
Safety features:
|
No
|
|
Marketing authorization holder:
|
aniMedica GmbH
|
|
Marketing authorization number:
|
1913
|
|
Marketing authorization issued on:
|
June 30, 2015
|
|
Marketing authorization expires on:
|
Unlimited
|
|
Marketing authorization procedure type:
|
Mutual recognition
|
|
Assessment report:
|
(last updated January 11, 2016)
|
|
Package code
|
Name of medicinal product
|
Dosage form
|
Package
|
Legal status
|
Reimbursements
|
Reference price
|
Last imported
|
PƤritolumaa
|
Additional information
|
|
1677247
|
Animedazon
|
cutaneous spray, suspension
|
2,45% w/w 211ml 1TK
|
Prescription
|
|
|
10.05.2016
|
|
|
|
1677258
|
Animedazon
|
cutaneous spray, suspension
|
2,45% w/w 211ml 12TK
|
Prescription
|
|
|
13.12.2022
|
|
|
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription
You can download Acrobat Reader fromhere